IDeaL Pilot Study - Infliximab Dose to Level: Pilot Study

NCT02847884 · clinicaltrials.gov ↗

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Inflammatory Bowel Disease
Crohn's Disease

Interventions

BIOLOGICAL: Infliximab

Sponsor

University of Alberta

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]